期刊文献+

乳头状甲状腺癌患者血清和甲状腺组织中白细胞介素6水平的检测及其意义 被引量:6

Detection of interleukin-6 levels in serum and thyroid tissue of patients with papillary thyroid carcinoma and their significances
下载PDF
导出
摘要 目的:探讨白细胞介素6 (IL-6)与乳头状甲状腺癌(PTC)发病的关系,阐明IL-6在PTC发生发展中的作用及其可能机制。方法:收集5例PTC患者(病例1组)、5例桥本甲状腺炎(HT)并发PTC患者(病例2组)和5名查体正常人(正常组)的血清,采用酶联免疫吸附(ELISA)法检测各组研究对象血清中IL-6水平。收集20例PTC (PTC组)、15例HT并发PTC患者(HT+PTC组)病变甲状腺组织和18名正常人(对照组)甲状腺组织,采用免疫组织化学(IHC)法检测各组研究对象甲状腺组织中IL-6、IL-6受体(IL-6R)、核因子κB (NF-κB)和RET/PTC蛋白表达阳性率;分析IL-6、IL-6R与RET/PTC、NF-κB表达的关联性。结果:PTC患者甲状腺组织内上皮细胞复杂乳头状增生伴细胞核毛玻璃样,并见核沟及核内包涵体;HT并发PTC患者甲状腺组织中除了PTC典型病变外,还可以看见弥漫淋巴组织浸润伴淋巴滤泡形成,增生与萎缩甲状泡上皮共存伴甲状腺上皮嗜酸性变,间质纤维化;正常甲状腺组织小叶结构存在,滤泡细胞大小一致。ELISA法检测,PTC组和HT并发PTC组患者血清IL-6水平高于正常组(P<0.05);IHC法检测,PTC组患者甲状腺组织中IL-6、IL-6R、NF-κB和RET/PTC表达阳性率高于对照组(P<0.05)。IL-6、IL-6R与NF-κB、RET/PTC蛋白表达有关联(P<0.05)。结论:IL-6可能通过RET/PTC-NF-κB信号通路参与PTC的发生发展。 Objective:To investigate the relationship between interleukin-6(IL-6)and papillary thyroid carcinoma(PTC),and to elucidate the role of IL-6 in the occurrence and development of PTC and its possible mechanism.Methods:The serum levels of IL-6 were measured by ELISA method in 5 patients with PTC(case 1 group),5 patients with Hashimoto thyroiditis(HT)complicated with PTC(case 2 group)and 5 normal persons(normal group).The thyroid tissues of 20 patients with PTC(PTC group),15 patients with HT complicated with PTC(HT +PTC group)and 18 normal persons(control group)were collected.The positive expression rates of IL-6,IL-6 receptor(IL-6 R),nuclear factor kappa-B(NF-κB)and RET/PTC proteins in thyroid tissue of the subjects in various groups were detected by immunohistochemistry(IHC)method;the relationships between IL-6,IL-6 Rand NF-κB,RET/PTC expressions were analyzed.Results:In the patients with PTC,the complex papillary hyperplasia of thyroid epithelial cells accompanying with ground glass like nuclei and nuclear sulcus and inclusions were seen;in the patients with HT complicated with PTC,in addition to the typical pathological changes of PTC,the diffuse lymphoid tissue infiltration accompanying with lymphoid follicle formation,and the coexistence of hyperplasia and atrophic thyroid follicular epithelium with eosinophic degeneration of thyroid epithelium and interstitial fibrosis were also found.The lobular structrure of normal thyroid tissue was found,and the follicular cells were in the same size The ELISA results showed that the serum IL-6 levels of the patients in PTC group and HT+ PTC group were higher than those in normal group(P<0.05);the IHC results showed that the positive expression rates of IL-6,IL-6 R,NF-κB,and RET/PTC in thyroid tissue of the patients in PTC group were higher than those in control group(P<0.05).The expressions of IL-6,and IL-6 R were positively correlated with the expressions of NF-κB and RET/PTC protein(P<0.05).Conclusion:IL-6 may be involved in the occurrence and development of PTC through the RET/PTC-NF-B signal pathway.
作者 黑利娟 王娟红 魏威 方航荣 段瑛 马士芬 徐俊荣 HEI Lijuan;WANG Juanhong;WEI Wei;FANG Hangrong;DUAN Ying;MA Shifen;XU Junrong(Department of Gastroenterology,Xi’ an Central Hospital, School of Medical Sciences, Xi’ an Jiaotong University,Xi ’an 710003, China;College of Medical Sciences, Yan’ an University,Yan’ an 716000, China;Department of Pathology, Xi’ an Central Hospital, School of Medical Sciences, Xi’ an Jiaotong University, Xi’ an 710003, China;Department of Pathology, Xi’ an Third Hospital,Shannxi Province, Xi’ an 710000, China)
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2019年第3期601-605,I0005,共6页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(81372857) 陕西省科技厅科技研究发展计划项目资助课题(2008K09-09) 陕西省西安市科技局科技计划项目资助课题[SF09027(9)]
关键词 甲状腺肿瘤 甲状腺乳头状癌 白细胞介素6 核因子ΚB RET/PTC papillary thyroid carcinoma interleukin-6 nuclear factor kappa-B RET/PTC
  • 相关文献

参考文献3

二级参考文献32

  • 1Beesley MF, McLaren KM. Cytokeratin 19 and galectin-3 immuno- histochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology, 2002, 41:236-243.
  • 2Sakorafas GH, Stafyla V, Bramis C, et al. Incidental parathyroidectomy during thyroid surgery: an underappreciated complication of thyroidectomy. World J Surg, 2005, 29:1539-1543.
  • 3Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev, 2005, 31:423-438.
  • 4Prasad ML, Pellegata NS, Huang Y, et al.Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol, 2005, 18:48-57.
  • 5Papotti M, Rodriguez J, De Pompa R, et al. Galeetin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol, 2005, 18:541-546.
  • 6Casey MB, Lohse CM, Lloyd RV. Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocr Pathol, 2003, 14:55-60.
  • 7Hunt JL, LiVolsi VA, Baloch ZW, et al. Microscopic papillary thyroid carcinoma compared with clinical carcinomas by loss of heterozygosity mutational profile. Am J Surg Pathol, 2003, 27: 159-166.
  • 8Kim TY, Kim WB, Song JY, et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf), 2005, 63:588-593.
  • 9Trovisco V, Soares P, Preto A, et al. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch, 2005, 446:589-595.
  • 10Sedliarou I, Saenko V, Lantsov D, et al. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma. Int J Oncol, 2004, 25:1729-1735.

共引文献28

同被引文献52

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部